Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification-Reference-Cited by-同舟云学术

Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification

Published:2023-01 Issue: Volume:175 Page:88-100
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Caliman Enrico,Fancelli Sara,Petroni Giulia,Gatta Michelet Marta Rita,Cosso Federica,Ottanelli Carlotta,Mazzoni Francesca,Voltolini Luca,Pillozzi Serena,Antonuzzo Lorenzo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference166 articles.

1. Small-cell lung cancer;van Meerbeeck;Lancet,2011

2. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J. Clin. Oncol.,2006

3. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer;Peifer;Nat. Genet.,2012

4. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer;Rudin;Nat. Genet.,2012

5. Comprehensive genomic profiles of small cell lung cancer;George;Nature,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer;New England Journal of Medicine;2024-09-13

2. Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients;Journal of the National Cancer Center;2024-09

3. EBV-positive small cell neuroendocrine carcinoma of nasopharynx as a probably unique subtype of neuroendocrine carcinoma: a clinicopathologic study of three cases and literature review;Diagnostic Pathology;2024-07-24

4. The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer;Cancer Treatment Reviews;2024-07

5. Efficacy and safety of novel immune checkpoint inhibitor‐based combinations versus chemotherapy as first‐line treatment for patients with extensive‐stage small cell lung cancer: A network meta‐analysis;Thoracic Cancer;2024-04-16